https://pipelinereview.com/Affini-T-Therapeutics-to-Present-AFNT-211-T-Cell-Product-Attributes-Targeting-KRAS-G12V-at-the-2023-American-Society-of-Clinical-Oncology-ASCO-Annual-Meeting/